Executive leadership at ACTUATE THERAPEUTICS.
Board of directors at ACTUATE THERAPEUTICS.
Research analysts covering ACTUATE THERAPEUTICS.
Recent press releases and 8-K filings for ACTU.
Actuate Therapeutics Enters $100 Million At-The-Market Equity Offering Agreement
ACTU
- Actuate Therapeutics, Inc. entered into an At the Market Issuance Sales Agreement on November 28, 2025, enabling the company to offer and sell shares of its common stock with an aggregate offering price of up to $100,000,000.
- The sales will be conducted through B. Riley Securities, Inc. and Craig-Hallum Capital Group LLC, who will act as sales agents and receive a commission of up to 3.0% of the gross sales proceeds.
- As of November 28, 2025, the aggregate market value of the company's outstanding voting and non-voting common equity held by non-affiliates was approximately $77.5 million.
Nov 28, 2025, 10:21 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more